J B Chemicals & Pharmaceuticals Ltd has recently launched Lek-Pamidol, a Nonionic Contrast Media, which is a high-tech researched product. Lek-Pamidol (Iopamidol), a "second generation" Nonionic Radio Contrast agent is used for intravascular applications in diagnostic radiology to determine the nature and extent of blockage in the arteries in the heart, brain, kidney etc.
JBCPL in house R&D has developed Lek-Pamidol (Iopamidol) Nonionic Contrast Media. The product is manufactured in JBCPLs Sate-of- the-Art manufacturing facility meeting cGMP requirements of the International Standards that ensures best quality product.
Nonionic Contrast Media Market in India is about Rs 500.00 million growing at 15 per cent. JBCPL is confident of acquiring market share of 10 per cent in the first year itself and establishing its leadership in the field of imaging technology in next three years.